New Regulatory Information Management Applications Added to ViewPoint Quantum Platform Advance Octagon's Regulatory Cloud Strategy
Octagon Research Solutions announced its two additions to its Quantum Regulatory Information Management platform. Content Manager and Document Publisher join Submission Manager as the next applications built on Octagon’s Quantum Platform. This new platform provides industry with a single, consolidated system to provide highly scalable, and top tier capabilities to life science companies.
The Quantum Content Manager Business Application provides process controls across the document lifecycle and offers a secure and collaborative environment for content creation, review, and finalization.
The Quantum Document Publisher Business Application provides PDF manipulation functionality supporting:
- Document navigation and the creation and modification of bookmarks and hyperlinks
- Document maintenance activities such as scaling, rotating and cropping
- Document enhancements such as the application of headers, footers and pagination
Combined with Octagon’s existing Submission Manager application, organizations have the capability to develop and publish content from a single, flexible, and pre-configured system.
“We are very pleased to be able to preview these two business modules that leverage the strong process management capabilities of the Quantum platform,” said James C. Walker, chairman and CEO, Octagon Research Solutions, Inc. “Content Manager and Document Publisher address the challenges of managing the document lifecycle while improving the quality, consistency and value of the final content deliverables.”
The two new business applications are integral components of Octagon’s cloud strategy. Though the Quantum platform and business modules are available in a traditional on-premise installation, the release of these new modules enables Octagon to provide an end-to-end, cloud-based solution that joins document and submissions lifecycles in a hosted environment.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
